Quantcast

Latest kidney cancer Stories

cbce1b31846d6e7fe2319fba6542aa8d1
2010-01-07 08:20:10

Mutations in the genome regulation machinery identified in clear cell renal cell carcinoma In a new study, scientists have searched for mutations in the gene regions of more than 100 kidney cancer samples, the largest number of samples from a single tumor type to be sequenced to date. Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, with 102,000 deaths worldwide each year. It is noteworthy because its pathology "“ all the visible clues to its nature...

2009-11-03 09:44:00

The NCCN Guidelines for Kidney Cancer have been updated to incorporate the recently approved therapy pazopanib as a treatment option for patients with advanced renal cell carcinoma. In conjunction with this update, NCCN presents a series of free webinars scheduled for the week of November 9, 2009, hosted by an NCCN Guidelines Panel Member to review the information that supported modification of the NCCN Guidelines. FORT WASHINGTON, Pa., Nov. 3 /PRNewswire-USNewswire/ -- Following the...

2009-10-19 17:30:00

SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive. Votrient is intended for people with advanced renal cell carcinoma, a type of kidney cancer...

2009-10-05 15:48:00

PHILADELPHIA, Oct. 5 /PRNewswire/ -- GlaxoSmithKline [NYSE: GSK] today announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in support of the approval of VOTRIENT(TM) (pazopanib). Specifically, the panel voted that the benefit-to-risk profile is acceptable for patients with advanced renal cell carcinoma (RCC). Pazopanib is an investigational, oral treatment for patients with advanced RCC. "Kidney cancer is a...

2009-09-25 11:57:00

FRIMLEY, England, September 25 /PRNewswire/ -- - This Press Release is Intended for Consumer Media Only - Afinitor More Than Doubles the Median Time Without Tumour Growth and Reduces the Risk of Disease Worsening or Death by 67% Compared With Placebo (2) - Patients With Advanced Kidney Cancer Have Limited Options Once Tumours Progress After First Line Standard Therapy(3) - Recently Published UK Expert Clinical Consensus Recommend Afinitor as Second-Line...

2009-05-14 17:00:00

WAYNE, N.J. and EMERYVILLE, Calif., May 14 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that more than 65 studies evaluating the use of Nexavar(R) (sorafenib) tablets will be presented at the 2009 American Society of Clinical Oncology (ASCO) annual meeting. "Nexavar has a proven track record in two cancers - in the treatment of unresectable hepatocellular carcinoma (HCC), or liver cancer, and in the treatment...

2009-05-12 09:00:00

New treatments are minimally invasive without the side effects of surgery NEW YORK, May 12 /PRNewswire/ -- See video from the Society of Interventional Radiology at: http://inr.mediaseed.tv/SIR_36322/ PROSTATE CANCER A minimally invasive interventional radiology treatment -- focal cryoablation that freezes prostate tumors -- proves as effective as surgery but without the side effects of sexual and urinary dysfunction. The so-called "male lumpectomy" can be considered a first-line...

2009-05-04 15:42:46

U.S. medical scientists say they've determined two types of kidney tumors previously thought to be different diseases are variations of the same one. Scientists from the Van Andel Research Institute in Grand Rapids, Mich., and the Cleveland Clinic said their finding will help physicians to more accurately diagnose the disease, and demonstrates the importance of using molecular data to diagnose cancer in general. The scientists said because adult cystic nephroma and mixed epithelial and...

2009-04-27 11:47:47

U.S. cancer researchers say they've determined outcomes of robot-assisted kidney cancer surgery are more beneficial to patients than open surgery. Medical scientists at the Fox Chase Cancer Center in Philadelphia led by Dr. Rosalia Viterbo said the da Vinci robot assisted surgical system for renal cell carcinoma has enabled faster and greater technical proficiency, allowing for quicker completion of complex surgical procedures, facilitating a minimally invasive approach for partial...

71e86ae7209c865153639539b27c2e7c1
2009-04-21 06:50:00

Fighting kidney cancer could be as easy as swapping your next steak for a plate of leafy greens, new research in the Journal of the American Dietetic Association shows. Researchers found that eating red meat may increase a person's risk of developing the most common type of kidney cancer, while eating vegetables may provide a protective effect. Kidney cancer is on the rise in the United States, and thus far, the best-documented risk factors for the disease are obesity and cigarette smoking....


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related